Nipro (TSE:8086) Cyclically Adjusted Revenue per Share: 円3,006.19 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:8086 Nipro Corp TSE:8086
72 GF Score
Price 円1,628.00
GF Value 円1,466.11
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nipro Cyclically Adjusted Revenue per Share?

Nipro TSE:8086 +3.69% 72 Cyclically Adjusted Revenue per Share is 円3,006.19 as of Mar. 2026. GuruFocus rates TSE:8086 with a GF Score™ of 72/100 and a GF Value™ of 円1,466.11 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Nipro's adjusted revenue per share for the three months ended in Mar. 2026 was 円941.080. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円3,006.19 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Nipro's average Cyclically Adjusted Revenue Growth Rate was 5.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Nipro was 9.00% per year. The lowest was 5.50% per year. And the median was 7.50% per year.

As of today (2026-07-27), Nipro's current stock price is 円1628.00. Nipro's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円3,006.19. Nipro's Cyclically Adjusted PS Ratio of today is 0.54.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nipro was 0.99. The lowest was 0.41. And the median was 0.54.


Nipro  (TSE:8086) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nipro's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1628.00/3006.19
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nipro was 0.99. The lowest was 0.41. And the median was 0.54.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Nipro Cyclically Adjusted Revenue per Share Related Terms


Nipro Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Nipro's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nipro Cyclically Adjusted Revenue per Share Chart

Nipro Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,203.40 2,433.24 2,626.48 2,853.14 3,006.19

Nipro Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,853.14 2,896.07 2,928.49 2,982.78 3,006.19

TSE:8086 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PS Ratio falls into.


TSE:8086
72GF Score
Nipro Corp TSE:8086
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nipro Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nipro's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=941.08/112.7000*112.7000
=941.080

Current CPI (Mar. 2026) = 112.7000.

Nipro Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 477.002 98.100 547.993
201609 475.601 98.000 546.941
201612 503.510 98.400 576.683
201703 488.485 98.100 561.185
201706 510.544 98.500 584.145
201709 514.502 98.800 586.886
201712 578.004 99.400 655.343
201803 553.244 99.200 628.534
201806 562.293 99.200 638.815
201809 575.247 99.900 648.952
201812 625.108 99.700 706.617
201903 583.098 99.700 659.129
201906 609.347 99.800 688.110
201909 626.558 100.100 705.425
201912 632.830 100.500 709.651
202003 648.663 100.300 728.857
202006 604.501 99.900 681.955
202009 629.214 99.900 709.834
202012 659.214 99.300 748.171
202103 701.883 99.900 791.814
202106 723.502 99.500 819.484
202109 761.013 100.100 856.805
202112 691.001 100.100 777.980
202203 682.020 101.100 760.274
202206 694.861 101.800 769.262
202209 719.684 103.100 786.696
202212 792.591 104.100 858.069
202303 754.839 104.400 814.850
202306 763.853 105.200 818.310
202309 789.105 106.200 837.402
202312 832.754 106.800 878.758
202403 802.023 107.200 843.172
202406 828.118 108.200 862.559
202409 866.181 108.900 896.406
202412 851.273 110.700 866.653
202503 898.133 111.100 911.067
202506 864.978 111.700 872.722
202509 859.245 112.000 864.615
202512 923.148 113.000 920.697
202603 941.080 112.700 941.080

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円3,006.19 mean?
Nipro (TSE:8086) has a Cyclically Adjusted Revenue per Share of 円3,006.19 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nipro and its competitors.
Is Nipro's Cyclically Adjusted Revenue per Share too high?
Nipro's current Cyclically Adjusted Revenue per Share is 円3,006.19. Overall, Nipro has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nipro's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Nipro's Cyclically Adjusted Revenue per Share of 円3,006.19 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nipro and its competitors. Nipro's current Cyclically Adjusted Revenue per Share is 円3,006.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nipro stock overvalued right now?
Based on GuruFocus' analysis, Nipro (TSE:8086) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,466.11, compared to a current price of 円1,628.00 — trading 11% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円3,006.19. Nipro's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Nipro (TSE:8086), the current Cyclically Adjusted Revenue per Share is 円3,006.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nipro (TSE:8086) Overvalued in 2026?

Based on GuruFocus' analysis, Nipro stock appears to be overvalued. The current stock price of 円1,628.00 is trading 11% above its estimated GF Value™ of 円1,466.11. GuruFocus considers Nipro to be Modestly Overvalued.

Key valuation signals for TSE:8086:

  • Cyclically Adjusted Revenue per Share: 円3,006.19
  • GF Value™: 円1,466.11 vs. price of 円1,628.00 (11% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the TSE:8086 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nipro Business Description

Other Exchanges 5FA:Germany
Address 3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
72GF Score

Get the complete analysis for TSE:8086

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,628.00
Price
円1,466.11
GF Value